A detailed history of Bessemer Group Inc transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Bessemer Group Inc holds 20,746 shares of DGX stock, worth $2.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,746
Previous 1,504 1279.39%
Holding current value
$2.84 Million
Previous $206,000 1463.11%
% of portfolio
0.01%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$137.09 - $137.09 $2.64 Million - $2.64 Million
19,242 Added 1279.39%
20,746 $3.22 Million
Q2 2024

Aug 13, 2024

SELL
$125.91 - $144.34 $83 Million - $95.1 Million
-658,979 Reduced 99.77%
1,504 $206,000
Q1 2024

May 13, 2024

SELL
$123.78 - $142.11 $29.5 Million - $33.8 Million
-238,118 Reduced 26.5%
660,483 $87.9 Million
Q4 2023

Feb 09, 2024

SELL
$120.62 - $141.12 $635,667 - $743,702
-5,270 Reduced 0.58%
898,601 $124 Million
Q3 2023

Nov 13, 2023

SELL
$121.86 - $144.92 $332,677 - $395,631
-2,730 Reduced 0.3%
903,871 $110 Million
Q2 2023

Aug 10, 2023

BUY
$130.56 - $146.84 $459,571 - $516,876
3,520 Added 0.39%
906,601 $127 Million
Q1 2023

May 10, 2023

BUY
$131.53 - $155.76 $21.6 Million - $25.6 Million
164,077 Added 22.2%
903,081 $128 Million
Q4 2022

Feb 13, 2023

BUY
$123.31 - $157.26 $1.01 Million - $1.29 Million
8,208 Added 1.12%
739,004 $116 Million
Q3 2022

Nov 09, 2022

BUY
$121.77 - $141.1 $1.01 Million - $1.17 Million
8,311 Added 1.15%
730,796 $89.7 Million
Q2 2022

Aug 10, 2022

BUY
$127.07 - $145.39 $1.95 Million - $2.23 Million
15,367 Added 2.17%
722,485 $96.1 Million
Q1 2022

May 12, 2022

BUY
$129.09 - $164.35 $1.07 Million - $1.36 Million
8,299 Added 1.19%
707,118 $96.8 Million
Q4 2021

Jan 27, 2022

BUY
$140.36 - $173.01 $2.27 Million - $2.8 Million
16,183 Added 2.37%
698,819 $121 Million
Q3 2021

Nov 12, 2021

BUY
$132.95 - $158.0 $824,024 - $979,284
6,198 Added 0.92%
682,636 $99.2 Million
Q2 2021

Aug 06, 2021

BUY
$126.66 - $141.48 $3.6 Million - $4.02 Million
28,417 Added 4.39%
676,438 $89.3 Million
Q1 2021

May 13, 2021

BUY
$114.63 - $133.34 $5.55 Million - $6.46 Million
48,439 Added 8.08%
648,021 $83.2 Million
Q4 2020

Feb 09, 2021

SELL
$112.7 - $128.05 $8.46 Million - $9.61 Million
-75,026 Reduced 11.12%
599,582 $71.5 Million
Q3 2020

Nov 12, 2020

SELL
$107.05 - $130.01 $32.5 Million - $39.5 Million
-303,621 Reduced 31.04%
674,608 $77.2 Million
Q2 2020

Aug 05, 2020

BUY
$73.34 - $122.61 $1.04 Million - $1.74 Million
14,182 Added 1.47%
978,229 $111 Million
Q1 2020

Apr 30, 2020

SELL
$75.14 - $115.68 $24.2 Million - $37.3 Million
-322,281 Reduced 25.05%
964,047 $77.4 Million
Q4 2019

Feb 04, 2020

BUY
$100.29 - $107.99 $51.3 Million - $55.2 Million
511,512 Added 66.02%
1,286,328 $137 Million
Q3 2019

Nov 07, 2019

BUY
$97.85 - $107.42 $382,104 - $419,475
3,905 Added 0.51%
774,816 $82.9 Million
Q2 2019

Jul 19, 2019

BUY
$85.18 - $101.94 $2.82 Million - $3.38 Million
33,153 Added 4.49%
770,911 $78.5 Million
Q1 2019

May 13, 2019

BUY
$80.68 - $89.92 $5.94 Million - $6.62 Million
73,604 Added 11.08%
737,758 $66.3 Million
Q4 2018

Feb 12, 2019

SELL
$79.75 - $108.38 $103 Million - $139 Million
-1,285,535 Reduced 65.94%
664,154 $55.3 Million
Q3 2018

Nov 06, 2018

SELL
$105.42 - $114.99 $2.1 Million - $2.29 Million
-19,873 Reduced 1.01%
1,949,689 $210 Million
Q2 2018

Jul 25, 2018

SELL
$97.35 - $113.14 $105,916 - $123,096
-1,088 Reduced 0.06%
1,969,562 $217 Million
Q1 2018

May 10, 2018

SELL
$96.42 - $107.88 $13.2 Million - $14.8 Million
-137,146 Reduced 6.51%
1,970,650 $198 Million
Q4 2017

Jan 30, 2018

BUY
$90.86 - $100.24 $80.8 Million - $89.2 Million
889,802 Added 73.05%
2,107,796 $208 Million
Q3 2017

Nov 03, 2017

BUY
$91.96 - $108.35 $112 Million - $132 Million
1,217,994
1,217,994 $114 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.